2021
DOI: 10.1186/s12920-021-00956-5
|View full text |Cite
|
Sign up to set email alerts
|

Susceptibility loci for pancreatic cancer in the Brazilian population

Abstract: Background Pancreatic adenocarcinoma (PA) is a very aggressive cancer and has one of the poorest prognoses. Usually, the diagnosis is late and resistant to conventional treatment. Environmental and genetic factors contribute to the etiology, such as tobacco and alcohol consumption, chronic pancreatitis, diabetes and obesity. Somatic mutation in pancreatic cancer cells are known and SNP profile by GWAS could access novel genetic risk factors for this disease in different population context. Here… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 59 publications
0
1
0
Order By: Relevance
“…More recently, germline genotyping for patients has been moving towards more assertive cohorts related to ethnicity, age, and the molecular and clinical characteristics of tumors [ 72 , 73 , 74 , 75 ]. The composition of the cohorts chosen, however, may bias the molecular epidemiology findings: A recent report using 2039 patients and 32,592 controls in the Japanese population identified three genome-wide significant loci (13q12.2, 13q22.1, and 16p12.3), among which 16p12.3 has not been reported in the Western population [ 76 ].…”
Section: Pancreatic Cancer Genomementioning
confidence: 99%
“…More recently, germline genotyping for patients has been moving towards more assertive cohorts related to ethnicity, age, and the molecular and clinical characteristics of tumors [ 72 , 73 , 74 , 75 ]. The composition of the cohorts chosen, however, may bias the molecular epidemiology findings: A recent report using 2039 patients and 32,592 controls in the Japanese population identified three genome-wide significant loci (13q12.2, 13q22.1, and 16p12.3), among which 16p12.3 has not been reported in the Western population [ 76 ].…”
Section: Pancreatic Cancer Genomementioning
confidence: 99%